Weekly Recap | Merck this week, vaccine data hits but partner tumblesWeekly Review·Oct 24, 2026 at 06:39 AMMRK-1.34%
Weekly Recap | Merck +0.24%, outperforming the S&P 500 with defensive strengthWeekly Review·Oct 17, 2026 at 07:42 AMMRK-1.34%
